Artios in strong position to accelerate cancer programmes after Arix investment 19 December 2018 | Media coverage
Artios Pharma Hooks Novartis & Pfizer In Over-Subscribed £65M Series B Round 19 December 2018 | Media coverage
Artios Pharma’s £65m Series B To Spur Development Of DDR Cancer Therapies 23 October 2018 | Media coverage
Interview with Artios’ CEO following Biotech and Money’s Awards 2017 16 November 2017 | Media coverage